Opportunity

Utah Public Procurement Place U3P #KR27-107

Five-year Sebia CAPILLARYS 3 DBS rental and reagent supply for Utah newborn screening

Posted

October 19, 2026

Respond By

October 26, 2026

Identifier

KR27-107

NAICS

532490, 423490, 811210, 541380

Utah is seeking a five-year Sebia CAPILLARYS 3 DBS rental and related supplies for newborn hemoglobinopathy screening at the Utah Public Health Laboratory. - Government buyer - Issuing procurement unit: Utah Department of Government Operations, Division of Purchasing. - Conducting agency: Utah Department of Health and Human Services (DHHS), Newborn Screening program; customer site: Utah Public Health Laboratory in Taylorsville. - OEM and vendor - Sebia, Inc. is the named manufacturer and vendor of the system, proprietary assays, reagents, and consumables. - Products requested - Rent 2 CAPILLARYS 3 DBS instruments, 2 UPS systems, and 2 processing-instrument computers. - Supply Sebia reagents and consumables as ordered. Listed products and part numbers include CAPILLARYS 3 NEONAT HEMOGLOBIN(E) (2506), CAPILLARYS 3 NEONAT HEMOLYZING SOLUTION (2563), NEONAT HB AF CONTROL (4757), HGB AFSC CONTROL - AGAROSE/CAPILLARYS (4792), CLEANPROTECT (5ML) (2059), CAPILLARYS 3 CAPICLEAN (2060), CAPILLARYS 3 WASH SOLUTION (2062), MICROPLATES CAPILLARYS 3 DBS (2578), CAPILLARYS 3 BINS FOR REAG. CUPS (2581), and CAPILLARYS 3 REAGENT CUPS (2582). Reagent quantities are not specified. - Services and notable requirements - Ship, install, configure, and verify the equipment; validate both screening platforms and train up to 2 laboratory staff on the system and Sebia software. - Provide emergency repair response within 48 hours on weekdays and 2 preventive-maintenance visits per instrument per year, plus subject-matter expertise as requested. - The system must perform capillary zone electrophoresis screening for hemoglobin disorders using dried blood spot samples. - The sole-source rationale cites Sebia’s proprietary technology and closed-system assays and reagents, and the claimed fit of CAPILLARYS 3 DBS for automated newborn screening. - Value and term - Estimated value: $219,936 annually and $1,099,680 over five years. - The rental agreement has a five-year initial term; renewal options are not specified. Sebia retains title to rental equipment, and the customer may purchase it at fair market value at the end of the initial term.

Description

This notice is for a proposed five-year agreement to rent a Capillary 3 DBS system and procure reagents and consumables for newborn screening of hemoglobin disorders using capillary electrophoresis. The scope includes two CAPILLARYS 3 DBS instruments, UPS systems, and processing computers, as well as installation, configuration, validation, staff training, emergency repair response, and preventive maintenance. The notice is an intent to award a contract without engaging in the standard procurement process, and vendors may submit a contest with documentation showing an alternative source that meets the specifications. The stated estimated value is $219,936 annually, totaling $1,099,680 for the agreement.

View original listing